Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Reuters NewMedia - November 13, 2008
Bappa Majumdar
India has the world's third highest caseload with 2.5 million infections. It has an estimated 200,000 intravenous drug users, many of whom are in the remote northeast region which borders the opium-producing Golden Triangle of Myanmar, Thailand and Laos.
"If we don't prevent new infections in new emerging populations like injecting drug users, it can go up as bushfires. We may see a major surge in infections," Peter Piot, the executive director of UNAIDS, said.
He also raised concerns about the spread of drugs in India. "Drug use is moving a bit everywhere, we can see it in Bihar, UP (Uttar Pradesh) and in Kashmir, it is kind of moving across the northern part of the country," Peter Piot, head of UNAIDS told Reuters.
"I was really shocked to hear what was going on."
Official figures show that more than 10 percent of intravenous drug users in India are infected with HIV, a higher prevalence than among prostitutes. The country's overall HIV/AIDS prevalence rate is about 0.9 percent for those aged between 15 and 49.
(Editing by Krittivas Mukherjee)
081113
RE081113
Copyright © 2008 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .